Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Rocklage Insider Profile
4 Followers
Scott Rocklage, Director at Cidara Therapeutics, holds 75.97K shares in Aprea Therapeutics (Ticker: APRE), holds 50.41K shares in Cidara Therapeutics (Ticker: CDTX), holds 2.55M shares in Epirus Biopharma (Ticker: EPRSQ). Most recently, Scott Rocklage Sold ― shares of Aprea Therapeutics on Jun 18, 2020 for an estimated value of 4.00M.
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+204.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scott Rocklage holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 14, 2015 - Apr 14, 2016
Return:+800.00%
The most profitable trade made by Scott Rocklage
Scott Rocklage's Trading History
Cidara Therapeutics
Apr 22, 2015
Director
Uninformative Buy
―
$657.88K
Aprea Therapeutics
Jun 18, 2020
Director
Informative Sell
4.00M
$390.08K
Epirus Biopharma
Feb 06, 2015
Director
Informative Buy
2.00M
$1.27M
Relypsa Inc
Nov 20, 2013
―
Informative Buy
103.00K
$1.02M
Achaogen
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Scott Rocklage's performance on stock
You May Also Like
Scott Rocklage insider profile FAQ
What is the percentage of profitable transactions made by Scott Rocklage?
The percentage of profitable transactions made by Scott Rocklage is 80%.
What is the average return per transaction made by Scott Rocklage?
The average return per transaction made by Scott Rocklage is 204.50%.
What stocks does Scott Rocklage hold?
Scott Rocklage holds: CDTX, APRE, EPRSQ, RLYP, AKAOQ stocks.
What was Scott Rocklage’s latest transaction?
Scott Rocklage latest transaction was an Informative Sell of $4.00M.
What was Scott Rocklage's most profitable transaction?
Scott Rocklage’s most profitable transaction was an Informative Buy of CDTX stock on April 14, 2015. The return on the trade was 800.00%.
What is Scott Rocklage's role in Cidara Therapeutics?
Scott Rocklage's role in Cidara Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.